News
Everybody wants their hands on NVIDIA's GPUs, with the AI favorite continuing to ink fresh deals and collaborate with many ...
GoodRx reports on identifying real Wegovy pens, which come in five colors and lack dose selectors. Counterfeits pose health ...
Here are nine new drug shortages and discontinuations, according to drug supply databases from the FDA and the American Society of Health-System Pharmacists.
More than one-third of people who helped develop the 2023 guidelines for treating children with obesity had undisclosed ...
Novo Nordisk sees 65% obesity drug sales growth, forecasts $8.14–$9.59B FY25 free cash flow. Click here to read an analysis ...
A lawsuit filed in federal court on behalf of the University of Pennsylvania and its health system alleges that 20 years of skyrocketing prices on drugs that treat diabetes, like insulin, can be ...
Explore more
GreensKeeper stays cautious amid frothy markets, betting on long-term value. Learn how disciplined investing can thrive when ...
Richmond, B.C. has been named Canada's Most Active Community and awarded the $100,000 grand prize to support local physical ...
The best stocks to invest in often are industry leaders in vast markets. These five stocks are likely to continue making ...
It isn't easy finding high-yield dividend growth stocks when the market is at an all-time high. Shares of Novo Nordisk and ...
India is emerging as a key player in the global weight management industry, driven by a rising obesity crisis and the impending patent expirations of blockbuster drugs. Pharmaceutical giants are ...
From the wind farms of Jutland to the rising skyline of NEOM, Denmark and Saudi Arabia are edging toward a new phase in their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results